INS and type 2 diabetes mellitus: The low levels of C-peptide in our population demonstrates the failure of pancreatic beta cells in patients living with a diabetes diagnosis for over 10 years and confirms the concept that T2DM patients often require the use of exogenous insulin to achieve glycemic control (7,16).